STAT6 and benign prostatic hyperplasia: Assessment of STAT6 showed no significant difference in the STAT6-IRS between the PCa (mean IRS ± SD: 2.0 ± 1.4) and BPH (mean IRS ± SD: 2.9 ± 2.2) groups.